Oliver Sartor presents interim results from the SPLASH trial at ESMO 2024, evaluating 177Lu-PNT2002 in PSMA-positive mCRPC following progression on ARPI therapy. The trial met its primary endpoint, ...

Parliament's winter session began with disruptions as the opposition clashed with the ruling party. Prime Minister Modi accused the opposition of obstructing proceedings, while the INDIA bloc ...

Similarly, Point has a treatment that was going through phase 3 trials at the time of the arrangement, as the company investigated PNT2002 for the treatment of metastatic-castration resistant ...

French plastic surgeon Olivier Gerbault, known as the “nose maestro,” has been suspended for two years following accusations of botched surgeries. Multiple patients allege that Gerbault, who ...

including additional clinical data from PNT2002’s init BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will ...

The revised policy will take effect on January 1, 2025.

including additional clinical data from PNT2002’s init BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will ...